Industry News

  • In The News

    Imaging has contributed to significant advances in healthcare delivery, leading to better health outcomes and reduced costs. Technology that was once unimaginable is now the medical standard of care. But that is just the tip of the iceberg. The next generation of imaging technologies will not only detect the location of a tumor, it will provide details about the molecular structure of the abnormal tissue within a single scan. In other words, imaging has not just obviated the need for exploratory surgery — it may also soon render biopsies obsolete.

  • In The News

    The Medical Imaging and Technology Alliance (MITA) announced a new campaign this week aimed at highlighting groundbreaking innovation in medical imaging technologies and the impact of these advances on patient care and healthcare delivery.

  • In The News

    The medical imaging industry has been challenged the past few years as it struggles to prove its value in a shifting health care environment. To show its worth, the Medical Imaging and Technology Alliance (MITA), the industry lobby, announced the launch of a brand new campaign called Imaging Forward on Monday.

  • In The News

    Advocates for the medical imaging industry are launching a campaign to highlight the technology’s value during a time of rising healthcare cuts. The Medical Imaging and Technology Alliance (MITA) said that the multi-platform effort will put a “long overdue spotlight” on how imaging has lowered healthcare costs by minimizing unnecessary procedures.

  • In The News

    The Medical Imaging and Technology Alliance (MITA) also applauded the committee leadership for the deal.

  • In The News

    “We believe that if colonography is approved for coverage and reimbursement that we will be able to increase the percentage of folks who get screened,” Gail Rodriguez, executive director of MITA, told DOTmed News. “There’s a large number of people today who don’t get the recommended screening and we think that with this test, which is just as sensitive as colonoscopy, a lot more people will be screened and live longer.”

  • In The News

    Supporters of PET amyloid imaging said they will continue to fight for coverage. “We are committed to working with the Centers for Medicare & Medicaid Services and other experts to generate additional clinical evidence to support coverage for beta amyloid PET for Medicare beneficiaries in the United States,” said Gail Rodriguez, executive director of MITA.

  • In The News

    “Over the years, Congress and Medicare administrators have tried to enact harmful policies — indiscriminately cutting payments, blocking coverage of new technologies, and erecting bureaucratic barriers to patient care,” said Gail Rodriguez, MITA’s executive director, in a statement. “A thoughtful, evidence-based appropriate use criteria policy is a much better approach to guiding medical imaging utilization. Appropriate use criteria empower physicians by providing them with the latest information to help inform the discussion with their patients on what care is best.”